Mon.Apr 23, 2018

article thumbnail

ASA Submits Recommendations to FDA for International Rescheduling of Cannabis

Americans for Safe Access

This week, we submitted comments relating to the efficacy and medical usefulness of cannabis as a medical treatment. In early April, the Food and Drug Administration (FDA) issued a notice in the federal register asking for public comments on cannabis and its derivatives. These comments will help inform the response of the United States to the World Health Organization in potentially reclassifying cannabis.

Food 129
article thumbnail

Screen Plants for Botrytis, Russet Mites with youPCR

Medicinal Genomics

We expanded our youPCR Plant Screening Platform to include two new youPCR detection assays for common cannabis plant pathogens: botrytis and russet mites. These early detection assays, along with our powdery mildew test , can help cannabis cultivators identify infected plants before they show visual signs. Cultivators can use these tests as a preventative measure to reduce the risk of a costly pathogen outbreak.

article thumbnail

Marijuana and Autism

The Herb Collective

About 1 percent of the children around the world suffer from autism. Autism is a mental disorder that makes communication, forming relationships, speaking and understanding abstract concepts difficult. Marijuana is being researched as a treatment for autism in more severe cases where patients are more violent and symptoms are more intense. There are several types of drugs prescribed for autism such as Ritalin.